Nalaganje...
The future of cancer treatment: immunomodulation, CARs and combination immunotherapy
In the past decade, advances in the use of monoclonal antibodies (mAbs) and adoptive cellular therapy to treat cancer by modulating the immune response have led to unprecedented responses in patients with advanced-stage tumours that would otherwise have been fatal. To date, three immune-checkpoint-b...
Shranjeno v:
| izdano v: | Nat Rev Clin Oncol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2016
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5551685/ https://ncbi.nlm.nih.gov/pubmed/26977780 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrclinonc.2016.25 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|